InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million) representing 22% growth YoY and up 1% sequentially compared to the prior quarter.
Q1 2023 Financial Highlights
-
Gross profit after effect of fair value was NIS 34.3 million ($9.4 million), compared to NIS 39.4 million in Q1 2022.
-
Gross margin of 33% compared to 41% in Q1 2022.
-
Adjusted EBITDA for the …